Viewing Protocol Section

Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section


Ignite Creation Date: 2024-07-17 @ 11:22 AM
Last Modification Date: 2024-10-26 @ 3:32 PM
Study NCT ID: NCT06462105
Protocol Section: NCT06462105
Start Identification Module Data
Brief Title: Liposomal Irinotecan Combination Regimen for First-line Treatment of Small Cell Lung Cancer
Official Title: Randomized Phase II Clinical Study of Liposomal Irinotecan or Etoposide Combined With Carboplatin and Serplulimab as First-line Treatment for Extensive Stage Small Cell Lung Cancer
Acronym: None
Organization: Guangzhou Institute of Respiratory Disease
Organization Class: OTHER
Organization Study ID: ES-2024-072-02
Start Status Module Data
Status Verified Date: 2024-06
Overall Status: NOT_YET_RECRUITING
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: Zhou Chengzhi
Lead Sponsor Class: OTHER
Lead Sponsor: Zhou Chengzhi
Start Oversight Module Data
Description Module:
Study Last Update Post Date Type(Status Module):
Attachment: Upload